Emad Shash: Cancer-Associated Thrombosis
Emad Shash, General Manager of the Breast Cancer Comprehensive Center of the National Cancer Institute at Cairo University, shared on LinkedIn:
“I’m thrilled to share a special episode on ‘Cancer-Associated Thrombosis’ as part of our كلام حكيم series! This episode dives into the latest insights on prevention, diagnosis, and treatment, offering practical tips on how healthcare providers can enhance the quality of life for patients facing cancer and associated thrombotic risks.
A heartfelt thank you to Sanofi Egypt for their generous sponsorship, which has made it possible to bring trusted, educational content to our audience.
Watch the episode now! I look forward to hearing your thoughts and feedback.”
In this episode, Emad Shash, Medical Oncologist at the National Cancer Institute, introduces crucial information about the risks and prevention of lung metastases in cancer patients. He explains that cancer patients are at a higher risk of developing metastases due to the spread of cancer cells through the bloodstream, as seen in cases where a tumor in the leg leads to lung metastases.
Shash emphasizes the importance of early detection and prevention, highlighting that while lung metastases can be life-threatening, they can be preventable through medical advice, routine screenings, and adherence to treatment protocols. He outlines symptoms that may signal metastasis-related complications, such as swelling, redness, or pain in the leg, which could indicate deep vein thrombosis. Severe symptoms like chest pain and shortness of breath require urgent medical attention.
The episode underscores the need for proactive health management and adherence to medical recommendations to reduce the risks of metastasis and improve outcomes for cancer patients.
More posts featuring Emad Shash on oncodaily.com
Emad Shash is the General Manager of the Breast Cancer Comprehensive Center of the National Cancer Institute at Cairo University. He is also a Lecturer at Cairo University and Medical Oncologist at the National Cancer Institute.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023